Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2023 Filed Feb 14, 2023 22:56 UTC |
Williams Stuart GlenChief Operating Officer
|
GrantCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009319 · doc4.xml · nonDerivative · entry 1 Williams Stuart Glen · CIK 0001942706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,465 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:49 UTC |
Surdykowski Andrew JGeneral Counsel
|
Tax withholdingCommon Stock | 885 | $108.71 | $96,208.35 |
DisclosureSEC source: 0001209191-23-009314 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,288 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,905 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:49 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantCommon Stock | 2,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009314 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,173 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:46 UTC |
Kapani MayurChief Technology Officer
|
Tax withholdingCommon Stock | 1,756 | $108.71 | $190,894.76 |
DisclosureSEC source: 0001209191-23-009310 · doc4.xml · nonDerivative · entry 2 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,832 F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 42,665 shares of common stock and 9,167 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:46 UTC |
Kapani MayurChief Technology Officer
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009310 · doc4.xml · nonDerivative · entry 1 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,588 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 120 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: Amount of securities beneficially owned includes 93 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:44 UTC |
Martin Lynn CPresident, NYSE Group
|
Tax withholdingCommon Stock | 2,645 | $108.71 | $287,537.95 |
DisclosureSEC source: 0001209191-23-009308 · doc4.xml · nonDerivative · entry 2 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,523 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 32,378 shares of common stock and 2,560 unvested restricted stock units ("RSUs"), and 13,585 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:44 UTC |
Martin Lynn CPresident, NYSE Group
|
GrantCommon Stock | 5,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009308 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,168 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:42 UTC |
Foley DouglasSVP, HR & Administration
|
Tax withholdingCommon Stock | 470 | $108.71 | $51,093.70 |
DisclosureSEC source: 0001209191-23-009306 · doc4.xml · nonDerivative · entry 2 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,094 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,264 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:42 UTC |
Foley DouglasSVP, HR & Administration
|
GrantCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009306 · doc4.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,564 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:43 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 3,227 | $108.71 | $350,807.17 |
DisclosureSEC source: 0001209191-23-009307 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,077 F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 103,499 shares of common stock and 18,578 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:43 UTC |
Jackson BenjaminPresident
|
GrantCommon Stock | 7,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009307 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,304 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:42 UTC |
Edmonds Christopher ScottChief Development Officer
|
Tax withholdingCommon Stock | 1,163 | $108.71 | $126,429.73 |
DisclosureSEC source: 0001209191-23-009304 · doc4.xml · nonDerivative · entry 2 Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,754 F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,427 shares of common stock and 3,944 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:42 UTC |
Edmonds Christopher ScottChief Development Officer
|
GrantCommon Stock | 2,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009304 · doc4.xml · nonDerivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,917 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:34 UTC |
Gardiner WarrenChief Financial Officer
|
Tax withholdingCommon Stock | 137 | $109.35 | $14,980.95 |
DisclosureSEC source: 0001209191-23-008022 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,482 F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, the remaining 450 shares were issued on February 7, 2023, of which 137 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,831 shares of common stock and 1,561 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 16:36 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 136 | $109.35 | $14,871.60 |
DisclosureSEC source: 0001209191-23-008027 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,258 F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, the remaining 450 shares were issued on February 7, 2023, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,420 shares of common stock and 438 unvested restricted stock units ("RSUs"), and 5,400 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:59 UTC |
Gardiner WarrenChief Financial Officer
|
Tax withholdingCommon Stock | 134 | $108.32 | $14,514.88 |
DisclosureSEC source: 0001209191-23-007835 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,619 F1 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 438 shares were issued on February 6, 2023, of which 134 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 438 shares are scheduled to be issued on February 5, 2024 and taxes for this issuance will be withheld and reported at the time of vesting. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,518 shares of common stock and 2,011 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 17:00 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 132 | $108.32 | $14,298.24 |
DisclosureSEC source: 0001209191-23-007841 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,394 F1 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 438 shares were issued on February 6, 2023, of which 132 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 438 shares are scheduled to be issued on February 5, 2024 and taxes for this issuance will be withheld and reported at the time of vesting. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,106 shares of common stock and 888 unvested restricted stock units ("RSUs"), and 5,400 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:37 UTC |
Gardiner WarrenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 12,780 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007527 · doc4.xml · derivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,780 Underlying: Common Stock · 12,780 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:41 UTC |
Namkung James WChief Accounting Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 4,381 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007537 · doc4.xml · derivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 Underlying: Common Stock · 4,381 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:42 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 108,633 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007542 · doc4.xml · derivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,633 Underlying: Common Stock · 108,633 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:44 UTC |
Williams Stuart GlenChief Operating Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 10,954 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007549 · doc4.xml · derivative · entry 1 Williams Stuart Glen · CIK 0001942706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,954 Underlying: Common Stock · 10,954 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:43 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 10,954 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007545 · doc4.xml · derivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,954 Underlying: Common Stock · 10,954 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:40 UTC |
Martin Lynn CPresident, NYSE Group
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 20,083 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007533 · doc4.xml · derivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,083 Underlying: Common Stock · 20,083 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:40 UTC |
Kapani MayurChief Technology Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 14,606 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007531 · doc4.xml · derivative · entry 1 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,606 Underlying: Common Stock · 14,606 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:38 UTC |
Jackson BenjaminPresident
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 32,863 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007530 · doc4.xml · derivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,863 Underlying: Common Stock · 32,863 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:35 UTC |
Foley DouglasSVP, HR & Administration
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 5,477 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007525 · doc4.xml · derivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,477 Underlying: Common Stock · 5,477 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:35 UTC |
Edmonds Christopher ScottChief Development Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 16,431 | $0.00 Strike: $107.66 | $0.00 |
DisclosureSEC source: 0001209191-23-007523 · doc4.xml · derivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,431 Underlying: Common Stock · 16,431 shares Expires 2033-02-03 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 17:37 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GiftCommon Stock | 67,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060564 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188,207 F1 · shares: This transaction involved a gift of 67,000 shares of the Issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,128,363 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 23:42 UTC |
Martin Lynn CPresident, NYSE Group
|
Tax withholdingCommon Stock | 654 | $107.09 | $70,036.86 |
DisclosureSEC source: 0001209191-22-060251 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,911 F1 · shares: Represents shares of restricted stock issued to the filing person on December 3, 2021. The restricted stock units vest over three years (1/3 on December 3, 2022, 1/3 on December 3, 2023 and 1/3 on December 3, 2024). Of the 3,840 shares, 1,280 shares were issued on December 5, 2022, of which 654 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,560 shares are scheduled to be issued on December 3, 2023 and December 3, 2024 and taxes for these issuances will be withheld and reported at the time of vesting. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 29,766 shares of common stock and 2,560 unvested restricted stock units ("RSUs"), and 13,585 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 20:45 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,143 | $106.00 | $439,159.66 |
DisclosureSEC source: 0001209191-22-059127 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 2,971,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $105.80 - $106.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The reporting person indirectly owns 2,971,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 20:45 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 25,857 | $105.27 | $2,722,041.38 |
DisclosureSEC source: 0001209191-22-059127 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 2,975,848 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $104.80 - $105.79. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 22:38 UTC |
Foley DouglasSVP, HR & Administration
|
SaleCommon Stock | 1,600 | $105.98 | $169,568.00 |
DisclosureSEC source: 0001209191-22-058886 · doc4.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,934 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 17,104 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:50 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,000 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-22-057118 · doc4.xml · derivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 1,000 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:50 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 2,500 | $105.00 | $262,500.00 |
DisclosureSEC source: 0001209191-22-057118 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,507 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,124 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:50 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,000 | $41.59 | $41,590.00 |
DisclosureSEC source: 0001209191-22-057118 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,492 | $0.00 Strike: $67.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · derivative · entry 11 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,299 Underlying: Common Stock · 1,492 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 63,680 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · derivative · entry 10 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,680 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 1,590 | $95.79 | $152,299.10 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 8 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,001,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F9 · price: The price range for the aggregate amount sold by the direct holder is $95.65 - $95.98. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F10 · balance_after: As previously reported, the reporting person also indirectly owns 3,001,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 5,198 | $95.25 | $495,103.78 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,003,295 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F8 · price: The price range for the aggregate amount sold by the direct holder is $94.65 - $95.63. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 3,212 | $94.07 | $302,148.66 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,008,493 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F7 · price: The price range for the aggregate amount sold by the direct holder is $93.62 - $94.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 16,277 | $95.74 | $1,558,394.16 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255,207 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $95.60 - $95.98. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,195,363 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 43,299 | $95.22 | $4,122,926.45 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271,484 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $94.60 - $95.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 27,801 | $94.06 | $2,615,020.44 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314,783 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $93.59 - $94.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,492 | $67.00 | $99,964.00 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,342,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:44 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 63,680 | $41.37 | $2,634,441.60 |
DisclosureSEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:20 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-22-047994 · doc4.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,439 Underlying: Common Stock · 1,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:20 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,000 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-22-047994 · doc4.xml · derivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,000 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:20 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 2,500 | $107.00 | $267,500.00 |
DisclosureSEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,007 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,624 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:20 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,000 | $57.31 | $57,310.00 |
DisclosureSEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:20 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,000 | $41.59 | $41,590.00 |
DisclosureSEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.